These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2553430)

  • 1. Biphasic effect of a kappa-opioid receptor agonist on plasma oxytocin levels in rats.
    Grell S; Fjalland B; Christensen JD
    Eur J Pharmacol; 1989 Jul; 166(1):41-8. PubMed ID: 2553430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of serum corticosterone in rats by bremazocine, a kappa-opioid agonist.
    Fuller RW; Leander JD
    J Pharm Pharmacol; 1984 May; 36(5):345-6. PubMed ID: 6145778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa-opioid receptor agonists differentially affect the release of neurohypophysial hormones.
    Fjalland B; Christensen JD
    Pharmacol Toxicol; 1990 Mar; 66(3):176-8. PubMed ID: 2159141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bremazocine-induced backwards walking behavior in rats is mediated via opioid kappa receptors.
    Shearman GT; Stenfors C
    Pharmacol Biochem Behav; 1986 Apr; 24(4):861-3. PubMed ID: 3012599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the kappa-agonist bremazocine on ingestive behaviour in mice and rats.
    Hartig U; Opitz K
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):4-12. PubMed ID: 6307194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic opioid kappa-receptor and regulation of the release of Met-enkephalin in the rat brainstem.
    Ueda H; Fukushima N; Ge M; Takagi H; Satoh M
    Neurosci Lett; 1987 Oct; 81(3):309-13. PubMed ID: 2829060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the respiratory depressant and analgesic effects of bremazocine, a kappa-agonist.
    Pazos A; Tristán C; Flórez J
    Life Sci; 1983; 33 Suppl 1():579-81. PubMed ID: 6319913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of nociceptive flexion reflex discharge by the kappa agonist bremazocine.
    Banna NR; Al-Amin HA; Jabbur SJ
    Neuropharmacology; 1987; 26(2-3):271-4. PubMed ID: 3035416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
    Salas SP; Roblero J; Ureta H; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):992-9. PubMed ID: 2550625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-noradrenergic interactions in the neurohypophysis. I. Differential opioid receptor regulation of oxytocin, vasopressin, and noradrenaline release.
    Zhao BG; Chapman C; Bicknell RJ
    Neuroendocrinology; 1988 Jul; 48(1):16-24. PubMed ID: 2845291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of a new opioid agonist on reproductive endocrine activity in rats of both sexes.
    Markó M; Römer D
    Life Sci; 1983 Jul; 33(3):233-40. PubMed ID: 6865656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-tetrahydrofurfuryl benzomorphans: comparison of a kappa and an agonist/antagonist analgesic.
    Wood PL
    Neuropeptides; 1985 Feb; 5(4-6):323-6. PubMed ID: 2987733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.
    Russell JA; Coombes JE; Leng G; Bicknell RJ
    J Physiol; 1993 Sep; 469():365-86. PubMed ID: 8271202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The opioid receptor subtypes mu and kappa, but not delta, are involved in the control of the vasopressin and oxytocin release in the rat.
    Van de Heijning BJ; Koekkoek-Van den Herik I; Van Wimersma Greidanus TB
    Eur J Pharmacol; 1991 Dec; 209(3):199-206. PubMed ID: 1665795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bremazocine causes sympatho-inhibition and hypotension in rabbits by activating peripheral kappa-receptors.
    Ensinger H; Hedler L; Szabo B; Starke K
    J Cardiovasc Pharmacol; 1986; 8(3):470-5. PubMed ID: 2425160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid kappa-receptor agonists suppress sexual behaviors in male rough-skinned newts (Taricha granulosa).
    Deviche P; Moore FL
    Horm Behav; 1987 Sep; 21(3):371-83. PubMed ID: 2822565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration.
    Summy-Long JY; Rosella-Dampman LM; McLemore GL; Koehler E
    Neuroendocrinology; 1990 Apr; 51(4):376-84. PubMed ID: 1971712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bremazocine is an agonist at kappa-opioid receptors and an antagonist at mu-opioid receptors in the guinea-pig myenteric plexus.
    Corbett AD; Kosterlitz HW
    Br J Pharmacol; 1986 Sep; 89(1):245-9. PubMed ID: 3026544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.